These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16626892)

  • 1. Radiation dose to the internal pudendal arteries from permanent-seed prostate brachytherapy as determined by time-of-flight MR angiography.
    Gillan C; Kirilova A; Landon A; Yeung I; Pond G; Crook J
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):688-93. PubMed ID: 16626892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predicting an increased dose to the penile bulb in permanent seed prostate brachytherapy.
    Taussky D; Haider M; McLean M; Yeung I; Williams T; Pearson S; Lockwood G; Crook J
    Brachytherapy; 2004; 3(3):125-9. PubMed ID: 15533803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy?
    Potters L; Calugaru E; Jassal A; Presser J
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1014-9. PubMed ID: 16682144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry.
    Neill M; Studer G; Le L; McLean M; Yeung I; Pond G; Crook JM
    Brachytherapy; 2007; 6(3):173-9. PubMed ID: 17681239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technical acquisition and dosimetric assessment of iodine-125 permanent brachytherapy in localized prostate cancer: our first series of 100 patients.
    Tanaka N; Asakawa I; Kondo H; Tanaka M; Fujimoto K; Hasegawa M; Konishi N; Hirao Y
    Int J Urol; 2009 Jan; 16(1):70-4. PubMed ID: 19120529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation between D90 and outcome for I-125 seed implant monotherapy for localised prostate cancer.
    Ash D; Al-Qaisieh B; Bottomley D; Carey B; Joseph J
    Radiother Oncol; 2006 May; 79(2):185-9. PubMed ID: 16701911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
    Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
    Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk.
    Crook JM; Potters L; Stock RG; Zelefsky MJ
    Brachytherapy; 2005; 4(3):186-94. PubMed ID: 16182218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications.
    Zelefsky MJ; Yamada Y; Cohen GN; Sharma N; Shippy AM; Fridman D; Zaider M
    Radiother Oncol; 2007 Aug; 84(2):185-9. PubMed ID: 17692978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvements in prostate brachytherapy dosimetry due to seed stranding.
    Lin K; Lee SP; Cho JS; Reiter RE; DeMarco JJ; Solberg TD
    Brachytherapy; 2007; 6(1):44-8. PubMed ID: 17284385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs.
    Beaulieu L; Archambault L; Aubin S; Oral E; Taschereau R; Pouliot J
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1298-308. PubMed ID: 15001275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI-based preplanning in low-dose-rate prostate brachytherapy.
    Tanaka O; Hayashi S; Matsuo M; Nakano M; Kubota Y; Maeda S; Ohtakara K; Deguchi T; Hoshi H
    Radiother Oncol; 2008 Jul; 88(1):115-20. PubMed ID: 17933407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical improvement in permanent seed implantation: a two-stage brachytherapy system. Description and comparison with current technique.
    Grimm PD; Blasko JC; Sylvester JE; Heaney C; Gasparich J; Quackenbush J; Gottesman J; Downey J; Grier D; Roddy T; Nellans R; Sood N; Wahl D
    Brachytherapy; 2004; 3(1):34-40. PubMed ID: 15110312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of dosimetry between high-dose-rate and permanent prostate implant brachytherapies in patients with prostate adenocarcinoma.
    Wang Y; Sankreacha R; Al-Hebshi A; Loblaw A; Morton G
    Brachytherapy; 2006; 5(4):251-5. PubMed ID: 17118319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loose seeds vs. stranded seeds: a comparison of critical organ dosimetry and acute toxicity in (125)I permanent implant for low-risk prostate cancer.
    Saibishkumar EP; Borg J; Yeung I; Cummins-Holder C; Landon A; Crook JM
    Brachytherapy; 2008; 7(2):200-5. PubMed ID: 18362087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.
    Nobes JP; Khaksar SJ; Hawkins MA; Cunningham MJ; Langley SE; Laing RW
    Radiother Oncol; 2008 Jul; 88(1):121-6. PubMed ID: 18499289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy.
    Crook J; McLean M; Yeung I; Williams T; Lockwood G
    Brachytherapy; 2004; 3(2):55-60. PubMed ID: 15374536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PSA kinetics and PSA bounce following permanent seed prostate brachytherapy.
    Crook J; Gillan C; Yeung I; Austen L; McLean M; Lockwood G
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):426-33. PubMed ID: 17869662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four-year experience of interstitial permanent brachytherapy for Japanese men with localized prostate cancer.
    Ishiyama H; Satoh T; Kitano M; Tsumura H; Kotani S; Okusa H; Uemae M; Baba S; Hayakawa K
    Jpn J Clin Oncol; 2008 Jul; 38(7):469-73. PubMed ID: 18577509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative adaptive brachytherapy of iodine-125 prostate implants guided by C-arm cone-beam computed tomography-based dosimetry.
    Westendorp H; Hoekstra CJ; van't Riet A; Minken AW; Immerzeel JJ
    Brachytherapy; 2007; 6(4):231-7. PubMed ID: 17991620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.